ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 2 filers reported holding ALBANY MOLECULAR RESH INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $2,967,000 | +42.0% | 136,400 | +41.6% | 0.17% | +27.4% |
Q2 2017 | $2,090,000 | +30.3% | 96,307 | -15.7% | 0.14% | +23.9% |
Q1 2017 | $1,604,000 | -25.2% | 114,300 | 0.0% | 0.11% | -30.1% |
Q4 2016 | $2,144,000 | +13.6% | 114,300 | 0.0% | 0.16% | -18.3% |
Q3 2016 | $1,887,000 | +22.9% | 114,300 | 0.0% | 0.19% | +6.7% |
Q2 2016 | $1,536,000 | -3.7% | 114,300 | +9.6% | 0.18% | -8.7% |
Q1 2016 | $1,595,000 | -56.7% | 104,300 | -48.9% | 0.20% | -18.0% |
Q4 2015 | $3,683,000 | +106.7% | 204,100 | +99.5% | 0.24% | +4.4% |
Q3 2015 | $1,782,000 | -14.7% | 102,300 | -1.0% | 0.23% | -6.5% |
Q2 2015 | $2,089,000 | +24.2% | 103,300 | 0.0% | 0.24% | +19.5% |
Q4 2014 | $1,682,000 | -41.5% | 103,300 | -27.7% | 0.20% | -44.9% |
Q2 2014 | $2,873,000 | -3.9% | 142,800 | -11.2% | 0.37% | -11.8% |
Q1 2014 | $2,989,000 | +9.6% | 160,800 | -40.6% | 0.42% | +2.4% |
Q4 2013 | $2,727,000 | -26.3% | 270,500 | -5.7% | 0.41% | -35.1% |
Q3 2013 | $3,699,000 | – | 287,000 | – | 0.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 302,400 | $4,243,000 | 7.26% |
Permian Investment Partners, LP | 3,181,577 | $44,638,000 | 6.90% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 1,738,764 | $24,395,000 | 2.25% |
AMERICAN CAPITAL MANAGEMENT INC | 2,157,370 | $30,268,000 | 2.14% |
Walthausen & Co., LLC | 831,285 | $11,663,000 | 1.20% |
Netols Asset Management, Inc. | 371,226 | $5,208,000 | 1.17% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,234,440 | $17,319,000 | 0.84% |
AMI ASSET MANAGEMENT CORP | 705,493 | $9,898,000 | 0.74% |
Evercore Wealth Management, LLC | 1,040,211 | $14,594,000 | 0.57% |
Lombard Odier Asset Management (USA) Corp | 421,100 | $5,908,000 | 0.56% |